BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13921756)

  • 1. Chromatographic studies of purine metabolism. V. Inhibition mechanism of diazo-oxo-norleucine in wild-type and in diazo-oxo-norleucine-resistant Escherichia coli.
    TOMISEK AJ; REID MR
    J Biol Chem; 1962 Mar; 237():807-11. PubMed ID: 13921756
    [No Abstract]   [Full Text] [Related]  

  • 2. 6-DIAZO-5-OXO-L-NORLEUCINE INHIBITION OF ESCHERICHIA COLI.
    COGGIN JH; MARTIN WR
    J Bacteriol; 1965 May; 89(5):1348-53. PubMed ID: 14293024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. V. Microbiologic studies of mode of action.
    MAXWELL RE; NICKEL VS
    Antibiot Chemother (Northfield); 1957 Feb; 7(2):81-9. PubMed ID: 24544268
    [No Abstract]   [Full Text] [Related]  

  • 4. Chromatographic studies of purine metabolism. II. The mechanism of E. coli inhibition by A-methopterin.
    TOMISEK AJ; KELLY HJ; REID MR; SKIPPER HE
    Arch Biochem Biophys; 1958 Jul; 76(1):45-55. PubMed ID: 13560011
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas.
    TARNOWSKI GS; STOCK CC
    Cancer Res; 1957 Nov; 17(10):1033-9. PubMed ID: 13489704
    [No Abstract]   [Full Text] [Related]  

  • 6. Biosynthesis of the purines. XV. The effect of aza-L-serine and 6-diazo-5-oxo-L-norleucine on inosinic acid biosynthesis de novo.
    LEVENBERG B; MELNICK I; BUCHANAN JM
    J Biol Chem; 1957 Mar; 225(1):163-76. PubMed ID: 13416227
    [No Abstract]   [Full Text] [Related]  

  • 7. Transport mechanisms of 6-diazo-5-oxo-L-norleucine in Escherichia coli K-12.
    Williams MV
    Microbiologica; 1982 Jan; 5(1):57-61. PubMed ID: 7050636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 6-diazo-5-oxo-1-norleucine (DON) on pregnancy.
    JACKSON D; ROBSON JM; WANDER AC
    J Endocrinol; 1959 Mar; 18(2):204-7. PubMed ID: 13641559
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease.
    MAGILL GB; MYERS WP; REILLY HC; PUTNAM RC; MAGILL JW; SYKES MP; ESCHER GC; KARNOFSKY DA; BURCHENAL JH
    Cancer; 1957; 10(6):1138-50. PubMed ID: 13489662
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the effects of 5-oxo-6-diazo-norleucine and albizziin on the biosynthesis of anthranilic acid in Saccharomyces cerevisiae].
    Lingens F; Lück W; Müller G
    Hoppe Seylers Z Physiol Chem; 1965; 343(4):282-9. PubMed ID: 5328312
    [No Abstract]   [Full Text] [Related]  

  • 11. Purine metabolism in bacteria. V. Feed-back inhibition.
    GOTS JS
    J Biol Chem; 1957 Sep; 228(1):57-66. PubMed ID: 13475295
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of Escherichia coli glucosamine synthetase by novel electrophilic analogues of glutamine--comparison with 6-diazo-5-oxo-norleucine.
    Walker B; Brown MF; Lynas JF; Martin SL; McDowell A; Badet B; Hill AJ
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2795-8. PubMed ID: 11133094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The purine metabolism of Escherichia coli.
    KOCH AL; PUTNAM FW; EVANS EA
    J Biol Chem; 1952 May; 197(1):105-12. PubMed ID: 12981039
    [No Abstract]   [Full Text] [Related]  

  • 14. Utilization of purine and pyrimidine compounds in nucleic acid synthesis by Escherichia coli.
    BOLTON ET; REYNARD AM
    Biochim Biophys Acta; 1954 Mar; 13(3):381-5. PubMed ID: 13140351
    [No Abstract]   [Full Text] [Related]  

  • 15. Purine metabolism in bacteria. III. Accumulation of a new pentose-containing arylamine by a purine-requiring mutant of Escherichia coli.
    LOVE SH; GOTS JS
    J Biol Chem; 1955 Feb; 212(2):647-54. PubMed ID: 14353866
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the relationship of potassium to metabolism and purine biocynthesis in Escherichia coli.
    FRIEDMAN S; FOX CL
    J Bacteriol; 1954 Aug; 68(2):186-93. PubMed ID: 13183927
    [No Abstract]   [Full Text] [Related]  

  • 17. A purine-histidine relationship in Escherichia coli.
    BALIS ME; LEVIN DH; LUZZATI D
    J Biol Chem; 1955 Sep; 216(1):9-16. PubMed ID: 13252002
    [No Abstract]   [Full Text] [Related]  

  • 18. The purine and pyrimidine metabolism of normal and phage-infected Escherichia coli.
    FRIEDMAN S; GOTS JS
    J Biol Chem; 1953 Mar; 201(1):125-35. PubMed ID: 13044781
    [No Abstract]   [Full Text] [Related]  

  • 19. Purine metabolism in bacteria. II. Factors influencing biosynthesis of 4-amino-5-imidazolecarboxamide by Escherichia coli.
    GOTS JS; LOVE SH
    J Biol Chem; 1954 Sep; 210(1):395-405. PubMed ID: 13201601
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of purine intermediates by a cell-free extract of Escherichia coli.
    LOVE SH
    J Bacteriol; 1956 Nov; 72(5):628-31. PubMed ID: 13376508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.